Open Beta
MetriLume

US marketsCAMP

SEC-sourced researchBeta

CAMP

Camp4 Therapeutics Corp

Company comparison ↗

Data passport

CIK
0001736730
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 28, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 652,000.0000 USD; December 2025: 3,498,000.0000 USD3.5M USD0 USD0December 2024December 2025
CAMP · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024652,000.0000Mar 5, 2026
December 20253,498,000.0000Mar 5, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20253,498,000.0000-80,403,000.0000-29,553,000.0000117,808,000.000070,104,000.0000Mar 5, 2026
December 2024652,000.0000-51,791,000.0000-45,562,000.000078,307,000.000015,163,000.0000Mar 5, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$3.5MDecember 2025Mar 5, 202610-K
Previous period revenueRevenues$652KDecember 2024Mar 5, 202610-K
Net incomeNetIncomeLoss-$80.4MDecember 2025Mar 5, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$29.55MDecember 2025Mar 5, 202610-K
Total assetsAssets$117.81MDecember 2025Mar 5, 202610-K
Total liabilitiesLiabilities$70.1MDecember 2025Mar 5, 202610-K

New filings

Explore methodology ↗